or Login to see your representatives.

Access Candidates' and Representatives' Biographies, Voting Records, Interest Group Ratings, Issue Positions, Public Statements, and Campaign Finances

Simply enter your zip code above to get to all of your candidates and representatives, or enter a name. Then, just click on the person you are interested in, and you can navigate to the categories of information we track for them.

Public Statements

Joe Pitts' Public Statements on Issue: Drugs

Full Name: Joseph 'Joe' R. Pitts
Office: U.S. House (PA) - District 16, Republican
First Elected: 11/05/1996
Last Elected: 11/06/2012
Next Election: 2014
On The Ballot: Running, Republican for U.S. House - District 16
General Nov. 4, 2014
Primary May 20, 2014
Gender: Male
Family: Wife: Virginia; 3 Children: Karen, Carol, Daniel
Birth Date: 10/10/1939
Birth Place: Lexington, KY
Home City: Kennett Square, PA
Religion: Protestant
Date Title
July 29, 2014 Committee's #RecordofSuccess Grows With Three More Bipartisan Bills Passed By the House
May 30, 2014 Pitts, Pallone Introduce Bipartisan Legislation to Crack Down on Anabolic Steroids
April 22, 2014 Letter to Margaret Hamburg, Commissioner of US Food and Drug Administration - Committee Presses FDA for Documents On Trial Lawyers' Role in Proposed Changes to Generic Drug Labeling
April 8, 2014 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Examining the Implementation of the Tobacco Control Act
April 7, 2014 Hearing of Health Subcommittee of the House Energy and Commerce Committee - Improving Predictability and Transparency in DEA and FDA Regulation
March 26, 2014 Pitts, Pallone Introduce Legislation to Speed New Therapies
Feb. 5, 2014 GOP Senate, House Lawmaker Inquiry Reveals Weak Administration Oversight of Drug Discount Program for Uninsured, Low-Income Americans
July 16, 2013 Health Subcommittee Continues Examination of Drug Compounding
July 16, 2013 Hearing of the House Health Subcommittee of the Energy and Commerce Committee - Reforming the Drug Compounding Regulatory Framework
June 14, 2013 Hearing of the House Health Subcommittee of the Energy and Commerce Committee - "Examining the Federal Government's Response to the Prescription Drug Abuse Crisis"
May 17, 2013 Pitts, Schakowsky, Whitfield and Eshoo Introduce Bill to End Doping of Racehorses
April 18, 2013 Letter to U.S. Secretary of State John Kerry - U.S.-Colombia Policy
June 20, 2012 Food and Drug Administration Safety and Innovation Act
May 30, 2012 Food and Drug Administration Reform Act of 2012
May 18, 2012 Racing Out of Control
March 8, 2012 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - "FDA User Fees 2012: Hearing on Issues Related to Accelerated Approval, Medical Gas, Antibiotic Development and Downstream Pharmaceutical Supply Chain
March 5, 2012 Grassley, Enzi, Hatch, Pitts Seek Details of Discount Drug Program
Feb. 9, 2012 Members Introduce Bipartisan Legislation to Improve FDA Generic Drug Approvals
Feb. 9, 2012 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages
Feb. 1, 2012 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Reauthorization of PDUFA: What It Means for Jobs, Innovation, and Patients
Dec. 7, 2011 Synthetic Drug Control Act of 2011
Nov. 4, 2011 Congress Has Not Been Waiting to Combat Drug Shortages
Oct. 27, 2011 Ongoing Investigation Reveals Chinese Firms Linked to Contaminated Heparin Still Supplying Crude Heparin to U.S.
Oct. 27, 2011 Investigation Shows Chinese Firms Linked to Contaminated Drugs Still Supplying the U.S.
Sept. 23, 2011 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - "Examining the Increase in Drug Shortages"
July 21, 2011 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Legislative Hearing to Address Bioterrorism, Controlled Substances and Public Health Issues
July 7, 2011 Health Subcommittee Examines FDA Regulatory Process
Dec. 16, 2010 Leading House Republicans Decry FDA Move on Breast Cancer Drug as a First Step Towards Rationing Care
May 30, 2010 Memorandum on Health Care Reform Legislation
June 25, 2009 Hearing Of The Health Subcommittee Of The House Committee On Energy And Commerce - Comprehensive Health Reform Discussion Draft, Day Three
June 11, 2009 Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Emerging Health Care Issues: Follow-On Biologic Drug Competition
May 1, 2008 Panel I of a Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Drug Safety Provisions of the Food and Drug Administration Globalization Act Discussion Draft Legislation
May 11, 2007 Time to Enforce Internet Gambling Laws
Sept. 22, 2006 The Friday Faxline (Issue 475, September 22, 2006)
June 17, 2005 Time For Changes At The UN
July 20, 2004 Floor Speech - Medicare Drug Discount Cards
July 20, 2004 Drug Discount Cards
May 21, 2004 Doing What's Right for Pennsylvania's Seniors
March 26, 2004 What changes can you expect to Medicare?
Back to top